secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0001493152-24-023111
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PowerUp Acquisition amends merger with Visiox: Outside Date extended to June 30, 2024
--------------------------------------------------------------------------------

- Outside Date moved from May 31 to June 30, 2024; PowerUp's indebtedness cap increased to $2M.
- Net tangible asset test eliminated; minimum cash condition reduced from $5M to $1.00.
- Visiox must use best efforts to complete labeling/compliance for inventory by June 30, 2024.
- Visiox must raise at least $500K capital by June 30; $350K allocated to labeling project.
- From May 30 to closing, Visiox cannot make expenditures over $1K without PowerUp's approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000149315224023111/0001493152-24-023111-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000149315224023111/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-023111

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer